The (11;14)(q13;q32) translocation in multiple myeloma - A morphologic and immunohistochemical study

被引:88
作者
Hoyer, JD
Hanson, CA
Fonseca, R
Greipp, PR
Dewald, GW
Kurtin, PJ
机构
[1] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA
关键词
t(11; 14)(q13; q32); multiple myeloma; cyclin D1; immunohistochemistry;
D O I
10.1309/4W8E-8F4K-BHUP-UBE7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We identified 24 cases of multiple myeloma with the t(11:14)(q13;q32). In 22 cases, the t(11;14)(q13;q32) was part of a complex karyotype, and in 2 cases it was an isolated abnormality. All patients had clinical and laboratory features consistent with multiple myeloma. The median degree of plasma cell involvement in the bone marrow was 60%, and in 10 cases, the plasma cells had a lymphoplasmacytoid appearance. Of the 24 cases, 21 had intermediate or high proliferative rates based on labeling index studies. Immunohistochemical studies performed on all bone marrow biopsy specimens showed strong cyclin D1 nuclear positivity in 19 cases. There also was strong cyclin D1 nuclear positivity found in 6 of 30 additional cases without the t(11;14)(q13;q32) demonstrated by routine cytogenetics. The t(11;14)(q13;q32) in multiple myeloma results in over-expression of the cyclin D1 protein, which can be demonstrated by immunohistochemical stain. The cyclin D1 stain results in the additional cases of multiple myeloma suggest that the t(11;14)(q13;q32) may be more common than previously thought and may be missed by routine cytogenetics, particularly if the proliferative rate is low.
引用
收藏
页码:831 / 837
页数:7
相关论文
共 48 条
[1]   MANTLE CELL LYMPHOMA - A PROPOSAL FOR UNIFICATION OF MORPHOLOGICAL, IMMUNOLOGICAL, AND MOLECULAR-DATA [J].
BANKS, PM ;
CHAN, J ;
CLEARY, ML ;
DELSOL, G ;
DEWOLFPEETERS, C ;
GATTER, K ;
GROGAN, TM ;
HARRIS, NL ;
ISAACSON, PG ;
JAFFE, ES ;
MASON, D ;
PILERI, S ;
RALFKIAER, E ;
STEIN, H ;
WARNKE, RA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (07) :637-640
[2]  
BOSCH F, 1994, BLOOD, V84, P2726
[3]   Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines [J].
Chesi, M ;
Bergsagel, PL ;
Brents, LA ;
Smith, CM ;
Gerhard, DS ;
Kuehl, WM .
BLOOD, 1996, 88 (02) :674-681
[4]   HUMAN C-MYC ONC GENE IS LOCATED ON THE REGION OF CHROMOSOME-8 THAT IS TRANSLOCATED IN BURKITT-LYMPHOMA CELLS [J].
DALLAFAVERA, R ;
BREGNI, M ;
ERIKSON, J ;
PATTERSON, D ;
GALLO, RC ;
CROCE, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (24) :7824-7827
[5]   Bcl-1 cyclin D1 in malignant lymphoma [J].
deBoer, CJ ;
vanKrieken, JHJM ;
Kluin, PM .
ANNALS OF ONCOLOGY, 1997, 8 :109-117
[6]  
DEWALD GW, 1985, BLOOD, V66, P380
[7]  
Donnellan R, 1998, J CLIN PATHOL-MOL PA, V51, P1
[8]   Cytogenetics and molecular genetics in multiple myeloma [J].
Feinman, R ;
Sawyer, J ;
Hardin, J ;
Tricot, G .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (01) :1-&
[9]  
FERTI A, 1987, CANCER GENET CYTOGEN, V12, P247
[10]   COMPARISON OF CHROMOSOME ANALYSIS AND BCL-1 REARRANGEMENT IN A SERIES OF PATIENTS WITH MULTIPLE-MYELOMA [J].
FIEDLER, W ;
WEH, HJ ;
HOSSFELD, DK .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (01) :58-61